Cargando…
When to use antibiotics in the cirrhotic patient? The evidence base
Bacterial infections are very common in advanced cirrhosis and are a leading cause of death of these patients. Early and appropriate empirical antibiotic treatment of infection is essential in determining patient’s outcome. A strategy of careful restriction of prophylactic antibiotics to the high-ri...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959942/ https://www.ncbi.nlm.nih.gov/pubmed/24714766 |
_version_ | 1782308098289958912 |
---|---|
author | Anastasiou, Jiannis Williams, Roger |
author_facet | Anastasiou, Jiannis Williams, Roger |
author_sort | Anastasiou, Jiannis |
collection | PubMed |
description | Bacterial infections are very common in advanced cirrhosis and are a leading cause of death of these patients. Early and appropriate empirical antibiotic treatment of infection is essential in determining patient’s outcome. A strategy of careful restriction of prophylactic antibiotics to the high-risk populations could contribute to the reduction of multidrug resistant bacteria. This article reviews and reports the current knowledge in the use of antibiotics in the cirrhotic patient. |
format | Online Article Text |
id | pubmed-3959942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hellenic Society of Gastroenterology |
record_format | MEDLINE/PubMed |
spelling | pubmed-39599422014-04-07 When to use antibiotics in the cirrhotic patient? The evidence base Anastasiou, Jiannis Williams, Roger Ann Gastroenterol Short Review Bacterial infections are very common in advanced cirrhosis and are a leading cause of death of these patients. Early and appropriate empirical antibiotic treatment of infection is essential in determining patient’s outcome. A strategy of careful restriction of prophylactic antibiotics to the high-risk populations could contribute to the reduction of multidrug resistant bacteria. This article reviews and reports the current knowledge in the use of antibiotics in the cirrhotic patient. Hellenic Society of Gastroenterology 2013 /pmc/articles/PMC3959942/ /pubmed/24714766 Text en Copyright: © Hellenic Society of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Review Anastasiou, Jiannis Williams, Roger When to use antibiotics in the cirrhotic patient? The evidence base |
title | When to use antibiotics in the cirrhotic patient? The evidence base |
title_full | When to use antibiotics in the cirrhotic patient? The evidence base |
title_fullStr | When to use antibiotics in the cirrhotic patient? The evidence base |
title_full_unstemmed | When to use antibiotics in the cirrhotic patient? The evidence base |
title_short | When to use antibiotics in the cirrhotic patient? The evidence base |
title_sort | when to use antibiotics in the cirrhotic patient? the evidence base |
topic | Short Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959942/ https://www.ncbi.nlm.nih.gov/pubmed/24714766 |
work_keys_str_mv | AT anastasioujiannis whentouseantibioticsinthecirrhoticpatienttheevidencebase AT williamsroger whentouseantibioticsinthecirrhoticpatienttheevidencebase |